Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Mander

Showing results (1-10 of 84) with videos related to

Pageof 9
Sort By:
Human Genomics|July 20, 2006
Stepwise haplotype analysis: are LD patterns repeatable?A P Mander, A Bansal
Trials|March 8, 2020
Designs for adding a treatment arm to an ongoing clinical trialMaxine Bennett, Adrian P Mander
Biochemical Society Transactions|October 28, 2004
Nitric oxide, hypoxia and brain inflammationP Mander, G C Brown
Obesity (Silver Spring, Md.)|October 15, 2013
How to use published complete case results from weight loss studies in a missing data sensitivity analysisLynne Cresswell, Adrian P Mander
Contemporary Clinical Trials|August 4, 2010
Two-stage designs optimal under the alternative hypothesis for phase II cancer clinical trialsA P Mander, S G Thompson
Pharmaceutical Statistics|March 14, 2012
Escalation strategies for combination therapy Phase I trialsMichael J Sweeting, Adrian P Mander
JCO Precision Oncology|December 24, 2021
Two-Stage Single-Arm Trials Are Rarely Analyzed Effectively or Reported AdequatelyMichael J Grayling, Adrian P Mander
Journal of Biopharmaceutical Statistics|February 23, 2022
Optimised point estimators for multi-stage single-arm phase II oncology trialsMichael J Grayling, Adrian P Mander
Statistics in Medicine|January 30, 2015
A product of independent beta probabilities dose escalation design for dual-agent phase I trialsAdrian P Mander, Michael J Sweeting
The Stata Journal|December 9, 2024
Calculations involving the multivariate normal and multivariate t distributions with and without truncationMichael J Grayling, Adrian P Mander
Pageof 9

Showing results (1-10 of 84) with videos related to

Sort By:
Pageof 9
Human Genomics|July 20, 2006
Stepwise haplotype analysis: are LD patterns repeatable?A P Mander, A Bansal
Trials|March 8, 2020
Designs for adding a treatment arm to an ongoing clinical trialMaxine Bennett, Adrian P Mander
Biochemical Society Transactions|October 28, 2004
Nitric oxide, hypoxia and brain inflammationP Mander, G C Brown
Obesity (Silver Spring, Md.)|October 15, 2013
How to use published complete case results from weight loss studies in a missing data sensitivity analysisLynne Cresswell, Adrian P Mander
Contemporary Clinical Trials|August 4, 2010
Two-stage designs optimal under the alternative hypothesis for phase II cancer clinical trialsA P Mander, S G Thompson
Pharmaceutical Statistics|March 14, 2012
Escalation strategies for combination therapy Phase I trialsMichael J Sweeting, Adrian P Mander
JCO Precision Oncology|December 24, 2021
Two-Stage Single-Arm Trials Are Rarely Analyzed Effectively or Reported AdequatelyMichael J Grayling, Adrian P Mander
Journal of Biopharmaceutical Statistics|February 23, 2022
Optimised point estimators for multi-stage single-arm phase II oncology trialsMichael J Grayling, Adrian P Mander
Statistics in Medicine|January 30, 2015
A product of independent beta probabilities dose escalation design for dual-agent phase I trialsAdrian P Mander, Michael J Sweeting
The Stata Journal|December 9, 2024
Calculations involving the multivariate normal and multivariate t distributions with and without truncationMichael J Grayling, Adrian P Mander
Pageof 9